Prior pre-eclampsia does not diminish the vascular protective effect of menopausal hormone therapy.

The use of MHT is associated with reduced CVD risk in women with prior pre-eclampsia. This is important to clinicians considering the initiation of MHT for recently menopausal women with prior pre-eclampsia.